Ireland women's cricketer Rebecca Stokell admitted breaching the International Cricket Council's anti-doping regulations on Tuesday, with the violation linked to her use of prescribed medication. Stokell provided a sample on June 23, 2026, during an in-competition test, which returned an adverse finding for a specified prohibited substance. Following notification of the anti-doping rule violation, Stokell admitted the breach and accepted a voluntary suspension effective October 23, 2026, pending the outcome of the disciplinary process. The ICC confirmed the case in an official statement but declined to provide further details while proceedings remain unresolved, saying no additional comments would be made until a decision had been reached. The circumstances surrounding Stokell's case have not been fully disclosed. Cricket Ireland's Director of High Performance, Graeme West, said the incident serves as a reminder that the Anti-Doping Rules are in place to protect both the sport and the athletes themselves. Stokell, who has 109 caps for Ireland, was last in action in the ODI series against England in early September. She said she accepted her mistake and hopes to add to her cap count. The case bears similarities to Australia pacer Megan Schutt, who was recently handed a two-match suspension for failing to adhere to guidelines governing prescription medication. Further information about the prohibited substance, length of suspension and the final outcome is awaited.